Project Grant HT94252310051
Award Date
12/30/22
Completion Date
12/29/25
Dollars Obligated
$579K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Nebraska Medical Center to support research targeting nuclear importins in pancreatic ductal adenocarcinoma (PDAC) under the Military Medical Research and Development program. The three-year award beginning July 1, 2022 will fund research exploring medical solutions for pancreatic cancer through investigation of nuclear transport proteins that mediate entry of molecules into the cell nucleus....
The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $556,200.00 project grant to the University of Nebraska Medical Center (UNMC) for "ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER". The award, with a period of performance from October 1, 2024 to September 30, 2027, will fund advanced biomedical research to develop innovative treatments for pancreatic cancer. UNMC, a prominent academic...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $183,220 to the University of Nebraska Medical Center (UNMC) to conduct research targeting the CCL17/CCR4 axis to eradicate lung cancer brain metastasis. The award period runs from February 1, 2025 to January 31, 2026. As a prominent academic research institution, UNMC will leverage its scientific expertise to advance innovative...
The U.S. Department of Defense's Defense Health Agency has awarded a $466,234 Project Grant to the University of Queensland in Australia to conduct "PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC." This research grant, funded through the Military Medical Research and Development program (CFDA 12.420), aims to develop innovative treatments and diagnostic tools to improve care for military service members, veterans, and their...
The Board of Regents of the University of Nebraska received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant funds research on "SOMATIC MUTATIONS IN NON-IG LOCI IN AUTOREACTIVE B CELLS AS DRIVERS OF LUPUS PATHOGENESIS AND DISEASE HETEROGENEITY" being conducted at the University of Nebraska Medical Center in Omaha, Nebraska from July 1, 2023 through June 30, 2025. The Military...